Antitumor properties of a vanadyl(iv) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosisElectronic supplementary information (ESI) available. See DOI: 10.1039/c3dt50524c

• Main Authors: Leon, I. E, Di Virgilio, A. L, Porro, V, Muglia, C. I, Naso, L. G, Williams, P. A. M, Bollati-Fogolin, M, Etcheverry, S. B
• Format: Journal Article
• Language: English
• Published: 31.07.2013
• DOI: 10.1039/c3dt50524c
• ISSN: 1477-9226

Flavonoids, a polyphenolic compound family, and the vanadium compounds have interesting biological, pharmacological, and medicinal properties. We report herein the antitumor actions of the complex [VO(chrysin) 2 EtOH] 2 (VOchrys) on the MG-63 human osteosarcoma cell line. Oxovanadium( iv ), chrysin and VOchrys caused a concentration-dependent inhibition of cell viability. The complex was the strongest antiproliferative agent ( p < 0.05). Cytotoxicity and genotoxicity studies also showed a concentration effect. Reactive oxygen species (ROS) and the alterations in the GSH/GSSG ratio underlie the main mechanisms of action of VOchrys. Additions of ROS scavengers (vitamin C plus vitamin E) or GSH to the viability experiments demonstrated beneficial effects ( p < 0.01). Besides, the complex triggered apoptosis, disruption of the mitochondria membrane potential (MMP), increased levels of caspase 3 and DNA fragmentation measured by the sub-G1 peak in cell cycle arrest experiments ( p < 0.01). Collectively, VOchrys is a cell death modulator and a promissory complex to be used in cancer treatments. Antitumor properties of a vanadium( iv ) complex with chrysin were evaluated in MG-63 osteosarcoma cells, studied by cyto-, genotoxicity and apoptosis.